{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Epigenetics > ORY1001CAS：1431326-61-2
Molecular Formula：C15H24N2Cl2
Molecular Weight：303.27
Storage：Powder:-20℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：Solid
Qty：
Size：
| CAS | 1431326-61-2 |
| Name | ORY1001 |
| Molecular Formula | C15H24N2Cl2 |
| Molecular Weight | 303.27 |
| Solubility | Soluble in Water |
| Purity | ≥98% |
| Appearance | Solid |
| Storage | Powder:-20℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| MDL | MFCD28900684 |
| SMILES | C1CC(CCC1N)NC2CC2C3=CC=CC=C3.Cl.Cl |
| InChIKey | UCINOBZMLCREGM-RNNUGBGQSA-N |
| InChI | InChI=1S/C15H22N2.2ClH/c16-12-6-8-13(9-7-12)17-15-10-14(15)11-4-2-1-3-5-11;;/h1-5，12-15，17H，6-10，16H2;2*1H/t12?，13?，14-，15+;;/m0../s1 |
| PubChem CID | 71664305 |
| Target Point | LSD1/KDM1A |
| Passage | Epigenetics |
| Background | ORY1001 is a selective lysine-specific demethylase LSD1/KDM1A inhibitor with oral activity that is highly selective to related FAD-dependent ammonia oxidase. |
| Unit | Bottle |
| Specification | 1mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
